Intelligence · Clinical Development
Pipeline search results
Programs matching “healthy” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 1,124 pipeline programs matching "healthy" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
CORT125236
CORCEPT THERAPEUTICS INC
Healthy
1 trial -
CORT125281-600
CORCEPT THERAPEUTICS INC
Healthy
1 trial -
CORT125329 lipid capsule formulation
CORCEPT THERAPEUTICS INC
Healthy
1 trial -
CPA 556-24
s.r.o.
healthy subjects, It is used in conditions with decreased immunity to enhance it e.g. in case of recurrent and chronic viral infections.
1 trial -
CPI-444 Capsules
Corvus Pharmaceuticals
Healthy Subjects
1 trial -
CPO25001
Lacuna Pharma Pty Ltd
No therapeutic indication in the current trial with healthy volunteers.
1 trial -
CRB-913
Corbus Pharmaceuticals Holdings
Obese But Otherwise Healthy Participants
1 trial -
CRB4101
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Healthy Adult Subjects
1 trial -
CRN00808
Crinetics Pharmaceuticals Europe GmbH
Healthy Volunteers
1 trial -
CRN01941 Oral Solution
Crinetics Pharmaceuticals Europe GmbH
Healthy Volunteers
1 trial -
CRN04894 Oral Solution
Crinetics Pharmaceuticals Europe GmbH
Healthy Volunteers
1 trial -
CSO24001
Lacuna Pharma Pty Ltd
No therapeutic indication in the current trial with healthy volunteers.
1 trial -
CT-G11
Celltrion Healthcare Australia Pty Ltd
Healthy
1 trial -
CT-P41
Celltrion Healthcare Australia Pty Ltd
Healthy Male Subjects
1 trial -
CT-P6 SC
Celltrion Healthcare Australia Pty Ltd
Healthy
1 trial -
CT1812
COGNITION THERAPEUTICS INC
Healthy Volunteers
1 trial -
CVL-354
BRIGHT MINDS BIOSCIENCES INC.
Healthy Participants
1 trial -
Calcichew D3
Takeda
Healthy Volunteers
1 trial -
Calcitriol
Takeda
Healthy
1 trial -
Carbamazepine
Aligos Therapeutics
Healthy Volunteer
1 trial -
Cardiovascular safety assessment of Tanimilast in healthy volunteers
Chiesi Farmaceutici S.p.A
This is Phase I study to assess the effect on the heart rate (HR) and cardiovascular safety according to electrocardiographic monitoring (including QT and QTc intervals) of CHF6001(Tanimilast) administered with NEXThaler® device in healthy adult volunteers.
1 trial -
Carvedilol 25 mg tablets
Teva Pharma GmbH
Healthy
2 trials -
Casdatifan
Arcus Biosciences
Healthy Participants
3 trials -
Cefadroxil 500 mg Capsules
Teva Pharma GmbH
Healthy
2 trials
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.